Lymph in Biological Technology

Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting

... lymph nodes ... lymph nodes ... and Neck lymph node ...

Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at ASGT Meeting

... An oral presentation entitled "Purging lymph Node Metastases with Adoptive T Cell Therapy, ... spreads to other parts of the body via the lymph nodes. In this study, the investigators ... T-cells pre-loaded with reovirus localize to lymph nodes, spleen and liver and deliver the virus ...

MammaPrint(R) Breast Cancer Test Validated in Lymph Node-Positive Breast Cancer Patients

... prognosis test in patients who have 1-3 positive lymph nodes. The data show that MammaPrint(R) can ... disease outcome. However, approximately 30% of lymph node-positive patients will remain free ... in the study. "Identifying patients with lymph node-positive disease who are at low risk of ...

ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery

... technology has the potential to better deliver DNA vaccines to draining lymph nodes to produce high levels of immune response using conventional ... enhance the delivery of polynucleotide-based antigens and SiRNA to lymph nodes. IVT has proven its scale-up capabilities at a contract ...

Trubion Announces Acceptance of Three Presentations on Its TRU-016 Product Candidate at the 2009 ASCO Annual Meeting

... as shown by a reduction in tumor lymphocyte blood counts, reduction in lymph node and spleen size, and/or an improvement in hematopoiesis, or the ... count. One patient had an increase in hemoglobin of 40% and a reduction in lymph nodes of 36%. Two patients had a significant increase in platelet count. ...

Assembling cells into artificial 3-D microtissues, including a tiny gland

... Gartner and Bertozzi constructed a minute gland analogous to a lymph node, for example such that one cell type secreted interleukin-3 and ... system that operates on the same principle and looks like a miniaturized lymph node, an arrangement where two cells communicate with each another and one ...

New Program Offers Breast Cancer Clinicians and Patients Support for Pre-Operative Clinical Assessment and Ongoing Surveillance of Lymphedema

... swelling of the upper and lower extremities due to the build-up of excess lymph fluid. This can occur when the lymphatic system, which is responsible for ... patients, this can occur after surgery, such as removal or biopsy of the lymph nodes, and/or radiation therapy. It is estimated that 6 percent to 40 ...

Cancer Care of Western New York Becomes First Center in Western New York to Treat Cancer with RapidArc(TM) Radiotherapy Technology from Varian Medical Systems

... turned out to be cancer that had started in his tonsil and spread to his lymph nodes. That was the bad news. Some good news followed, however. Kelver ... is a 72-year-old man with stage 3 lung cancer that has spread to his lymph nodes on both sides. "With earlier forms of radiation therapy, once a ...

First Taxane-Based Non-Anthracycline Containing Chemotherapy in Combination With Herceptin (TCH) for HER2 Positive Early Breast Cancer Patients Obtains Approval From the FDA

... (hormone receptor status), or whether or not the cancer had spread to lymph nodes (nodal status). There was no statistically significant difference in ... (hormone receptor status), or whether or not the cancer had spread to lymph nodes (nodal status). There was no statistically significant difference in ...

Kosan's Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer

... continuing on study after 7 months; -- 1 patient with 57% decrease in lymph nodes, liver and left breast lesions, continuing on study after 7 months; and -- 1 patient with 37% decrease in lymph nodes, continuing on study after 5 months. -- 2 patients ...

Genmab Announces Update on Recruitment of Patients in ofatumumab CLL Pivotal Study

... inappropriate candidates for alemtuzumab due to bulky tumor in their lymph nodes. An interim analysis will be conducted on this cohort when 24 week ... inappropriate candidates for alemtuzumab due to bulky tumor in their lymph nodes. Each group will be analyzed separately and it is hoped that, ...

New nanoparticle vaccine is more effective but less expensive

... they flow through the skins extracellular matrix, making a beeline to the lymph nodes. Within minutes, theyve reached a concentration of DCs thousands of ... as a danger signal, and to exploit the slow interstitial flow towards the lymph nodes are completely new. But it meant that our particles had to be much ...

New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation

... through the wall of the colon or rectum but has not yet spread to nearby lymph nodes. In stage III, the cancer has invaded one or more of the local lymph nodes but has not spread to distant sites. Metastatic (advanced) ...

Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress

... service contractor for the state of California, extended its coverage for Onco type DX to include breast cancer patients with one to three positive lymph nodes, effective June 28, 2009. Established a contract with Blue Cross Blue Shield Rhode Island, providing in-network benefit coverage for ...

MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus

... 20% of humans infected with WNV experience West Nile Feverwith clinical symptoms that include fever, headache, body aches, skin rash and swollen lymph glands. In approximately 1% of human infections, WNV enters the brain and causes severe, life-threatening neuroinvasive disease in the form of ...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

... Chemotherapy II-41 Surgical Procedures for Prostate Cancer II-41 Transurethral Resection of the Prostate (TURP) II-41 Prostatectomy and lymph Node Dissection II-42 Radical Prostatectomy II-42 Cryosurgery II-43 Advantages of Cryosurgery II-43 Disadvantages of Cryosurgery ...

New Report Just Published: World Endoscopy Systems Market Report

... II-5 Multi-Band Imaging II-5 NOTES - A New Dimension to Translumenal Endoscopy II-5 Other Technology Advancements Over The Years II-6 lymph Endoscopy II-6 Endoscopic Carpal Tunnel Release II-6 Endoscopic Metal Halide Technology II-6 2. Competitive Scenario II-7 Table 1: ...

CEL-SCI Corporation Releases Letter to Shareholders

... intact, except in the area of the tumor, and their lymphatics have not yet been cut, meaning that they can still deliver immune cells from the local lymph nodes to the tumor. From here on there is only one thing to do. We will launch the Phase III study as quickly as possible. Success would be ...

Varian Medical Systems Acquires Assets of IKOEmed and IKOEtech; Acquisition to Add Software for Accelerating Radiotherapy Treatment Planning

... of Varian Medical Systems. "This new tool should save a lot of time in planning for complex cases, particularly in cancers of the head and neck and lymph systems." The IKOE software, which has FDA 510(k) clearance, complements Varian's existing segmentation tools currently used to automate planning ...

OncoGenex Pharmaceuticals Announces OGX-011 Treatment Provides Survival Benefit in Randomized Phase 2 Trial in Advanced Metastatic Prostate Cancer

... significant predictors of overall survival were treatment arm, performance status, and presence of metastases other than in bone or lymph nodes. Patients treated with OGX-011 had a rate of death 51% lower than patients treated with docetaxel alone (HR=0.49; p=0.012). ...

ImmunoVaccine Technologies Partners with FIT Biotech to advance a therapeutic HIV vaccine

... of HIV in infected individuals. IVT's pre-clinical research demonstrates that DepoVax(TM) effectively delivers DNA plasmids into draining lymph nodes with as little as one dose. The DepoVax(TM) platform uses liposomes to encapsulate a target antigen, like GTU(R) MultiHIV, and adjuvant. ...

Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies

... blood of the transplanted mice was examined every four weeks, and after 16-18 weeks the blood-forming organs (bone marrow, spleen, thymus, and lymph nodes) of the mice were dissected. Transplants using mouse AFKL cells were found to be successful; newly formed white blood cells of all lineages ...

Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells

... of the lymphocytic line of white blood cells. CLL affects a particular lymphocyte, the B cell, which originates in the bone marrow, develops in the lymph nodes, and normally fights infection. In CLL, the DNA of a B cell is damaged, so that it can't fight infection, but it grows out of control and ...

Singapore Medicine - Breakthrough Development of Cell Therapy Treatment for Cancer

... it at some point in their lives. Of those affected, the majority suffer nothing more than mild afflictions, such as fever, sore throat or swollen lymph glands. However, some carriers of the virus eventually develop nasopharyngeal carcinoma, or cancer. To date, only two studies have been done on ...

Oncolytics Biotech Inc. Announces 2008 Second Quarter Results

... delivered at the American Society of Gene Therapy (ASGT) meeting covering work using the reovirus against mesothelioma, and also to purge lymph nodes of tumor cells. - Another two presentations were delivered at the American Association for Cancer Research (AACR) covering work using the ...

Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial

... in RET are also present in the tumor DNA of up to 50% of sporadic MTC patients with no familial history of thyroid cancer. MTC may metastasize to lymph nodes or other organs before it is ever diagnosed. Additionally, MTC does not take up radioactive iodine, which is commonly used to treat other types ...

Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia

... may progress over a period of years, ultimately producing a generalized depression of immunity, marked increases in the size of spleen, liver and lymph nodes, and impaired production of other normal blood cells. Eventually, these problems may cause life-threatening complications, such as overwhelming ...

Genetic Immunity To Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference

... that includes disease-specific plasmid DNA encoded antigens. DermaPrep is the topical administration device that delivers NanoComp into a patient's lymph node dendritic cells to induce T cell mediated immune responses that can treat a broad spectrum of diseases. These two components together make up ...

Oncothyreon's PX-478 is effective in preclinical model of human lung cancer

... mimics the disease in humans. Treatment with oral PX-478 for five days resulted in significant inhibition of tumor growth, marked reduction in lymph nodes metastases, decreased volume of pleural effusions, and significantly improved survival. PX-478 was effective in models of both non-small ...

Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer

... response mediated by anti-cancer Natural Killer (NK) cells, CD8+ lymphocytes and NK-T cells. This results in the activation of tumor-draining lymph nodes, cellular infiltration of distant tumors and tumor-cell death. Mounting the initial immune response in the GALT -- away from the primary tumor ...

Clarient to Commercialize Novel Breast Cancer Profile

... commercialize a novel breast cancer test, the first molecular test available that is applicable to all stages of operable breast cancer, including lymph node-positive patients. The new offering, called Clarient Insight(TM) Dx Breast Cancer Profile, will be sold by Clarient through an exclusive license ...

Multigene Test Predicts Who Could Avoid Chemotherapy Despite Positive Lymph Nodes in Early Breast Cancer

... cancer tumor specimens collected on this trial, and measured the same groups of genes already in use to predict outcomes and chemotherapy benefit in lymph node-negative disease. Up until this study, standard practice was to give chemotherapy to women with positive nodes. This study sought to determine ...

Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer

... study had received surgery for Stage I-III invasive breast cancer, meaning that the cancer was either localized to the breast or had spread to the lymph nodes under the adjacent arm. A total of 1016 patients were randomized between June 1997 and December 1999; 48% of patients had node-negative ...

National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment

... people age 50 or older. CLL is characterized by the accumulation of functionally immature white blood cells (lymphocytes) in the bone marrow, blood, lymph tissue, and other organs. Two types of lymphocytes are present in the blood, B cells and T cells. About 95 percent of CLL cases involve cancerous B ...

On the road to a new cancer therapy -- starving the tumor

... on multiplying out of control. The proliferating cells spread to surrounding tissue or are carried to other tissues and organs via the blood or the lymph system. This seriously disrupts our bodys vital functions − often with deadly consequences. Blood vessel formation (or angiogenesis) ...

Genta Completes Appeal of FDA Decision for Genasense(R) in CLL

... may progress over a period of years, ultimately producing a generalized depression of immunity, marked increases in the size of spleen, liver and lymph nodes, and impaired production of other normal blood cells. Eventually, these problems may cause life-threatening complications, such as overwhelming ...

Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers' Diarrhea Patch at Keystone Conference

... uses a patch placed on the surface of the skin to deliver vaccines and adjuvants via a group of antigen-presenting cells in the skin to the nearby lymph nodes, where a sustained immune response is triggered. ABOUT TRAVELERS' DIARRHEA This year, approximately 55 million international travelers will ...

Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkin's Lymphoma

... trials in hematological malignancies. About Hodgkin's Lymphoma Hodgkin's lymphoma (HL) is a cancer of the lymphatic system that begins in the lymph nodes and progresses to other organs, including the lungs, liver, bone and bone marrow. It is characterized by the presence of Reed-Sternberg cells. ...

Taming the anthrax threat

... growing organisms. That chance exists for a few hours when the invaders are inside immune cells in the lung and then pass from the lungs to the lymph nodes. Once the bacteria reach the bloodstream, they become unrecognizable to immune cells there. At this stage, they cause death from septicemia ...

FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia

... form of adult leukemia in the western world. B-CLL is characterized by the accumulation of functionally immature cells in the bone marrow, blood, lymph tissue and other organs. Because these cancerous B cells have a longer than normal life span, they begin to build up and "crowd out" normal, healthy ...